Great West Life Assurance CO Axsome Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 7,599 shares of AXSM stock, worth $716,737. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,599
Previous 7,370
3.11%
Holding current value
$716,737
Previous $588,000
3.91%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
288Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$437 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$353 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$311 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$223 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$175 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.04B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...